Diebold Nixdorf DBD Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $16.2M+27.6% | $5.5M+173% | $50.5M— | $41.7M+292% | $12.7M-14.2% | ||
| $30.8M-41.6% | $31.4M+153% | $30.7M+115% | $31.7M+199% | $52.7M+764% | ||
| $4.2M+27.3% | $3.2M+6.7% | $2.8M+21.7% | $3M+3.4% | $3.3M+26.9% | ||
| —— | $31.7M+102% | $217.5M+10.9% | $37.4M+341% | $30.1M+476% | ||
| —— | $20.2M— | -$38.6M-123% | -$26.2M-111% | -$32.8M— | ||
| $60.6M+101% | $60.4M+529% | $51.1M+2,122% | $39.9M+3,527% | $30.1M+2,215% | ||
| -$62.5M-99.7% | -$62.2M-386% | -$55.7M+71.0% | -$44.1M-859% | -$31.3M-163% | ||
| -$91.2M-265% | -$13.7M-254% | $124.7M+640% | -$32.6M-26.8% | -$25M+10.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Diebold Nixdorf's cash flow data come from?
- Every line is extracted from Diebold Nixdorf's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
